1. Home
  2. SONO vs ABCL Comparison

SONO vs ABCL Comparison

Compare SONO & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$15.77

Market Cap

1.8B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.83

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
ABCL
Founded
2002
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
SONO
ABCL
Price
$15.77
$5.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$19.67
$8.40
AVG Volume (30 Days)
2.2M
5.0M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
0.77
N/A
Revenue
$1,443,276,000.00
$75,128,000.00
Revenue This Year
$5.04
N/A
Revenue Next Year
$6.53
$21.85
P/E Ratio
$19.04
N/A
Revenue Growth
N/A
160.56
52 Week Low
$10.12
$2.75
52 Week High
$19.82
$8.44

Technical Indicators

Market Signals
Indicator
SONO
ABCL
Relative Strength Index (RSI) 53.88 47.88
Support Level $12.77 $3.40
Resistance Level $17.50 $6.79
Average True Range (ATR) 1.01 0.43
MACD 0.07 -0.07
Stochastic Oscillator 47.72 46.41

Price Performance

Historical Comparison
SONO
ABCL

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: